valoctocogene roxaparvovec aav gene transfer for severe hemophilia: results from phase 3 trial
Published 2 years ago • 302 plays • Length 5:00Download video MP4
Download video MP3
Similar videos
-
5:08
valoctocogene roxaparvovec gene transfer for severe haemophilia a on health-related quality of life
-
3:00
valoctocogene roxaparvovec aav gene therapy for patients with hemophilia a: new results
-
4:39
a post hoc analysis of the gener8 1 phase 3 trial
-
0:57
aav gene transfer for hemophilia
-
3:54
gener8-1 two-year analysis as presented at eahad
-
20:34
gene therapy for treatment of hemophilia: aav vector gene therapy application to hemophilia
-
5:51
final analysis from the pivotal phase 3 hope-b gene therapy trial
-
1:32:16
recent advances in gene therapy for hemophilia presented at nhf 2021
-
23:28
gene therapy for treatment of hemophilia: an introduction to aav vector gene transfer
-
3:58
follow-up of patients with hemophilia b treated with fidanacogene elaparvovec aav gene therapy
-
17:08
achievement of normal fviii activity following gene transfer with valoctocogene roxaparvovec…
-
5:50
long-term vector genome outcomes and immunogenicity of aav fviii gene transfer in hemophilia a
-
1:45
safety of valoctocogene roxaparvovec for patients with hemophilia a and hiv infection
-
1:02:04
multiyear factor viii expression after adeno‐associated virus gene transfer for hemophilia a
-
0:44
current aav hemophilia b gene therapy trials
-
3:07
aav-based gene therapy in hemophilia a and b: valoctocogene roxaparvovec & etranacogene dezaparvovec
-
2:43
hemophilia a nejm _genetic .therapy
-
3:38
gene therapy: an end to hemophilia
-
36:32
gene therapy for fviii